PennyMac Financial Services stock slides again as KBW cuts target and MSR runoff stays in focus

PennyMac Financial Services stock slides again as KBW cuts target and MSR runoff stays in focus

PennyMac Financial (PFSI) fell 5.3% to $94.58 Monday after KBW cut its price target to $115 from $143, citing concerns over faster mortgage prepayments and servicing rights runoff. The stock has dropped 38% since Jan. 29. Fourth-quarter net income was $106.8 million, with servicing segment pretax income plunging to $37.3 million. A law firm has launched a probe into the late-January share plunge.
2 February 2026
Pfizer stock (PFE) edges up ahead of Feb. 3 earnings as obesity pricing shifts and RSV dispute draw focus

Pfizer stock (PFE) edges up ahead of Feb. 3 earnings as obesity pricing shifts and RSV dispute draw focus

Pfizer shares rose 0.3% to $26.51 ahead of fourth-quarter and full-year 2025 results due Feb. 3. Analysts expect adjusted earnings of 57–58 cents per share on $16.7–16.9 billion revenue. Obesity drug price cuts and a UK ruling against Sanofi in an RSV dispute add pressure. Pfizer projects 2026 revenue of $59.5–62.5 billion, factoring in losses from COVID-19 products and patent expirations.
2 February 2026
Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus

Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus

Coherent shares jumped over 6% Monday, trading as high as $229.10 after Bystronic confirmed it completed the purchase of Coherent’s Tools for Materials Processing business. The company will report fiscal second-quarter results after markets close Feb. 4. Analysts expect earnings of $1.22 per share on $1.6 billion in revenue. Intraday volatility spiked ahead of the results, with options pricing in a 15% move by Feb. 6.
Boston Scientific stock price drops today: BSX slides as investors size up Feb. 4 earnings, Watchman trial date

Boston Scientific stock price drops today: BSX slides as investors size up Feb. 4 earnings, Watchman trial date

Boston Scientific shares fell 1.6% to $92.01 Monday, lagging sector peers as the S&P 500 rose. Investors are watching for the company’s Feb. 4 earnings call and the March 28 release of CHAMPION-AF trial results for its Watchman device. TD Cowen maintained a buy rating, citing potential upside if the trial data proves positive.
VSE Corporation stock dives as $1 billion share-and-unit sale spooks investors

VSE Corporation stock dives as $1 billion share-and-unit sale spooks investors

VSE Corporation shares fell 10.4% to $195.93 after announcing a $1 billion stock-and-unit offering to fund its acquisition of Precision Aviation Group. The company detailed a plan to raise $650 million in common stock and $350 million in tangible equity units, with additional debt financing. SEC filings show PAG posted $472 million in 2024 revenue and $6.8 million net income. Traders focused on dilution risk as the offering terms emerged.
2 February 2026
Goldman Sachs stock climbs as Fed chair nominee Warsh and strong factory data steady banks

Goldman Sachs stock climbs as Fed chair nominee Warsh and strong factory data steady banks

Goldman Sachs shares rose 1.3% to $947.36 Monday afternoon as U.S. banks rallied and the S&P 500 neared record highs. The ISM’s manufacturing index hit 52.6 in January, its first expansion in a year. The U.S. jobs report, scheduled for Friday, was delayed due to a partial government shutdown. Lawmakers began debating a bill to end the shutdown, with a House vote set for Tuesday.
Amphenol stock rebounds in New York trade as APH swings again — here’s what matters now

Amphenol stock rebounds in New York trade as APH swings again — here’s what matters now

Amphenol shares rose 1.2% to $145.85 Monday after swinging between $141.02 and $148.36, rebounding from last week’s 3.7% drop. The move followed record quarterly results and a $6.4 billion sales report, but the stock remains 13.8% below its Jan. 27 high. Wall Street’s broader rally lifted sector peers TE Connectivity and Eaton. Amphenol’s forecast includes $900 million in sales from its recent CCS acquisition.
2 February 2026
Rocket Lab stock slides again as RKLB pulls back from January highs

Rocket Lab stock slides again as RKLB pulls back from January highs

Rocket Lab shares fell 5.35% to $75.79 by Monday afternoon, extending losses to 24% below their January high. The drop follows reports that Congress pulled funding for NASA’s Mars Sample Return mission, for which Rocket Lab had proposed a $4 billion role. Investors remain focused on the company’s dependence on government contracts and delays in its Neutron rocket program. Rocket Lab will report Q4 and full-year results on Feb. 26.
Eldorado Gold stock sinks on Foran Mining buyout: what investors watch next

Eldorado Gold stock sinks on Foran Mining buyout: what investors watch next

Eldorado Gold shares fell about 9% Monday after announcing a deal to acquire Foran Mining, expanding its copper portfolio. The stock dropped $4.03 to $38.89 in New York trading. Foran shareholders will receive 0.1128 Eldorado shares plus C$0.01 per share, with the merger expected to close in Q2 pending approvals. Eldorado reports full-year earnings Feb. 19.
Bank of America stock rises as yields firm — here’s what could move BAC next

Bank of America stock rises as yields firm — here’s what could move BAC next

New York, February 2, 2026, 14:57 EST — Regular session Bank of America shares climbed roughly 1.4% to $53.94 in afternoon trading on the New York Stock Exchange Monday, bouncing back after an early slide. The stock gained around 74 cents from Friday’s $53.20 close, fluctuating between $52.99 and $54.08. Roughly 19.5 million shares traded hands. The stock’s move followed a broader shift in rates after Donald Trump nominated Kevin Warsh to head the Federal Reserve. The 10-year Treasury yield climbed about 0.03 percentage point to 4.271%. Traders also braced for policy decisions this week from the European Central Bank,
2 February 2026
1 92 93 94 95 96 1,639

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.02.2026

8 February 2026
LIVEMarkets rolling coverageStarted: February 8, 2026, 12:00 AM ESTUpdated: February 8, 2026, 12:11 AM EST Sprinklr (CXM) Undervalued Amid Share Price Drop, AI Growth Potential Assessed February 8, 2026, 12:11 AM EST. Sprinklr (CXM) shares hover near $6, reflecting a 21% drop over 30 days and nearly 31% decline year-to-date. Despite negative returns stretching back three years, some analysts see an intrinsic value of around $11, suggesting the stock may be undervalued. The AI-driven customer experience platform is integrating advanced AI functionalities across marketing and customer service products to capitalize on rising demand for AI-powered analytics. Key risks include potential
Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop